insights_auto
Why is EDIT up 3,97%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
2,62 $
arrow_upward
+3,97%(+0,100) 1D
2,60 $
arrow_downward
-0,76% (-0,020)bedtimeAfter hours
Closed: 2 հոկ, 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
2,57 $
High
2,63 $
Low
2,51 $
Mkt. cap
402,38 մլն
Avg. vol.
2,95 մլն
Volume
2,16 մլն
52-wk high
4,54 $
52-wk low
1,66 $
EPS
-0,74 $
Beta
2,00
Shares outstanding
153,58 մլն
No. of employees
87
Open
2,57 $
High
2,63 $
Low
2,51 $
Mkt. cap
402,38 մլն
Avg. vol.
2,95 մլն
Volume
2,16 մլն
52-wk high
4,54 $
52-wk low
1,66 $
EPS
-0,74 $
Beta
2,00
Shares outstanding
153,58 մլն
No. of employees
87
News stories
From web sources and news partners
Yahoo! Finance Canada
·
30 րոպե առաջ
CABA,RPC,TRIN,FFIN,NXRT,GO,BLCO,CULP,VSNT,VIRC,FRST,KWY,ENTX,GRNT,BLIN,SSP,GAIA,NRGV,AFCG,APCX,THRY,KLTR,BETR | Stock Prices | Quote Comparison
Foreign Policy Journal
·
51 րոպե առաջ
Microsoft (NASDAQ: MSFT) $678 Billion Backlog Raises Questions About Revenue Timing And Cash Conversion
Benzinga
·
24 րոպե առաջ
Getty Images Delists From NYSE, Shares Begin Trading Over The Counter Market
24/7 Wall St.
·
7 ժամ առաջ
Why Pay to Own U.S. Stocks? This Zero-Fee ETF Is Beating the S&P 500
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc